Enhanced antimicrobial efficacy of hydroxyapatite-based composites for healthcare applications
Scientific Reports · 02.11.2024 · 14 (1)
DOI: 10.1038/s41598-024-76088-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, online erschienen am 02.11.2024. Verfasst von Maher Hassanain und 4 weiteren Autor:innen. Beteiligte Einrichtung: Central Metallurgical Research and Development Institute (CMRDI), PO Box 87, Helwan, Cairo, 11421, Egypt. Hauptthemen laut MEDLINE: Durapatite, Silver, Escherichia coli, Metal Nanoparticles. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Metallurgical Research and Development Institute.
Abstract (Originalsprache)
Hydroxyapatite (HAp) and hydroxyapatite-based materials show promising potential in the healthcare sector due to their distinctive properties such as biocompatibility, antimicrobial efficacy, non-toxicity, and robust mechanical characteristics. This makes HAp materials play an important role in hindering infection spreading in healthcare provider institutions. This study assesses the antimicrobial efficacy of the developed hydroxyapatite-based composites incorporating copper, zinc, and silver nanoparticles. The synthesized HAp and its modified composite variants (Cu/HAp, Zn/HAp, and Ag/HAp) with varying ratios ranging from 0 to 15% (wt) were characterized using XRD, XPS, SEM, and TEM analyses. Furthermore, the antibacterial and antifungal properties of the synthesized HAp and HAp-based composites were evaluated. The antibacterial effectiveness of the HAp and its composites was evaluated using a modified disc diffusion test, where the resulting inhibition zones on the agar surface were observed. All the HAp and HAp-based composites (HAp, Cu/HAp, Zn/HAp, and Ag/HAp materials) elicited in the formation of inhibitory zones. The most substantial inhibition values were observed for the 5% Ag/HAp formulation, with values of 19.7 and 13.8, against E. coli and S. aureus, respectively. The 5% Ag/HAp concentration may strike an ideal balance, providing high antimicrobial activity without adverse effects on biocompatibility or material stability. These findings underscore the recommendation of the proposed HAp-based composites for infection control measures through their application on medical instruments, textiles, healthcare personnel attire, and patient garments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Metallurgical Research and Development Institute (CMRDI), PO Box 87, Helwan, Cairo, 11421, Egypt.
- Chemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, 11566, Egypt.
- Central Metallurgical Research and Development Institute (CMRDI), PO Box 87, Helwan, Cairo, 11421, Egypt. hamdy.maamoun@gmail.com.
- Dalian Engineering Research Center for Carbohydrate Agricultural Preparations, Liaoning Provincial Key Laboratory of Carbohydrates, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, CAS, Dalian, 116023,…
- Processes Development Department, Egyptian Petroleum Research Institute, Nasr City, Cairo, 11727, Egypt.
Förderung
- Central Metallurgical Research and Development Institute
Zitieren
APA
Hassanain, M., Abdel-Ghafar, H. M., Hamouda, H. I., El-Hosiny, F. I., & Ewais, E. M. M. (2024). Enhanced antimicrobial efficacy of hydroxyapatite-based composites for healthcare applications. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-76088-4
Vancouver
Hassanain M, Abdel-Ghafar HM, Hamouda HI, El-Hosiny FI, Ewais EMM. Enhanced antimicrobial efficacy of hydroxyapatite-based composites for healthcare applications. Scientific Reports. 2024;14(1). doi:10.1038/s41598-024-76088-4
BibTeX
@article{Hassanain2024,
author = {Hassanain, Maher and Abdel-Ghafar, Hamdy Maamoun and Hamouda, Hamed I and El-Hosiny, Fouad I and Ewais, Emad M M},
title = {Enhanced antimicrobial efficacy of hydroxyapatite-based composites for healthcare applications},
journal = {Scientific Reports},
year = {2024},
volume = {14},
number = {1},
doi = {10.1038/s41598-024-76088-4}
}
EUVIMED